Renalytix advances kidneyintelX.Dkd scale-up with laboratory expansion and CE submission

FDA extends review timeline for Sanofi's Sarclisa subcutaneous formulation in multiple myeloma

FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children

Inhibrx provides clinical update on ozekibart (INBRX-109) for colorectal cancer treatment

LENZ Therapeutics advances VIZZ regulatory expansion with UK submission for presbyopia treatment

Lundbeck presents new real-world data on VYEPTI (eptinezumab) at AAN 2026

European Commission approves Merck's ENFLONSIA for infant RSV prevention in Europe

Cumberland Pharmaceuticals secures FDA approval for expanded Caldolor indication

Philips secures FDA clearance for Spectral CT Verida system

Adimab partner GSK receives additional marketing approvals for depemokimab

Gallant reports positive pilot data for feline OA stem cell therapy and FDA eligibility for expanded conditional approval pathway

Asgard Therapeutics appoints chief medical officer

CS Analytical appoints director of Scientific Affairs

CrossBridge Bio to be acquired by Eli Lilly

IDEAYA Biosciences and Servier report positive results from Phase 2/3 trial of darovasertib/crizotinib combination